$ABVX News

ABIVAX (NASDAQ:ABVX) Flashes Strong Technical Rating and Breakout Setup

Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod

ABIVAX Société Anonyme (ENXTPA:ABVX) Adds Commercial Leaders, Is The Upside Already Priced In?

Abivax (ENXTPA:ABVX) Adds Commercial Leaders And Signs Valerio R And D Deal

Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments

Valerio Therapeutics Announces Development Collaboration with Abivax and Provides Pipeline Update

Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross?

Abivax CEO says $920M raise funds U.S. drug launch without Big Pharma

Piper Sandler Maintains Overweight on Abivax, Raises Price Target to $175

Abivax Announces Closing of $920 Million Public Offering

Is ABIVAX Société Anonyme (ABVX) A Good Stock To Buy Now?

ABVX Stock Eyes Over Six-Month High As Investors Double Down On Abivax's Lead Drug Bet – Buyout Chatter Builds

Abivax jumps as fully exercised option lifts share-sale haul to $920 million

Truist Securities Maintains Buy on Abivax, Raises Price Target to $155

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

ABIVAX (ENXTPA:ABVX) Stock Looks Expensive Even After Strong Trial Progress

Citizens Reiterates Market Outperform on Abivax, Maintains $187 Price Target

ABIVAX Société Anonyme (ABVX) Discusses ABTECT Maintenance Part 2 Results and Updated Obefazimod Safety and Efficacy Data in Ulcerative Colitis - Slideshow

Jefferies Upgrades Abivax to Buy, Raises Price Target to $158

Abivax: Latest Obefazimod Data Eases Safety Fears, Brings M&A Back Into Play